Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,910 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registry.
Chen CC, Chang SC, Chang YY, Lin BW, Chen HH, Hsieh YY, Hsu HC, Hsieh MC, Ke TW, Kuan FC, Wu CC, Lu WC, Su YL, Liang YH, Chen JB, Huang HY, Tsai HL, Wang JY. Chen CC, et al. Among authors: chen hh, chen jb. Am J Cancer Res. 2023 Dec 15;13(12):6333-6345. eCollection 2023. Am J Cancer Res. 2023. PMID: 38187069 Free PMC article.
Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.
Chang YT, Chen CC, Chang SC, Chang YY, Lin BW, Chen HH, Hsieh YY, Hsu HC, Hsieh MC, Kuan FC, Wu CC, Lu WC, Su YL, Liang YH, Chen JB, Huang SY, Huang CW, Wang JY. Chang YT, et al. Among authors: chen cc, chen hh, chen jb. Nutrients. 2023 Jun 30;15(13):2971. doi: 10.3390/nu15132971. Nutrients. 2023. PMID: 37447297 Free PMC article.
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan.
Yeh KH, Yang TS, Hsu TC, Tzu-Liang Chen W, Chen HH, Teng HW, Lin BW, Kuan FC, Chiang FF, Duann CW, Li YS, Lin MT, Fiala-Buskies S, Ducreux M, Wang JY. Yeh KH, et al. Among authors: chen hh. J Formos Med Assoc. 2021 Nov;120(11):2023-2031. doi: 10.1016/j.jfma.2020.12.015. Epub 2021 Jan 7. J Formos Med Assoc. 2021. PMID: 33422398 Free article.
Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment.
Chen HH, Ke TW, Huang CW, Jiang JK, Chen CC, Hsieh YY, Teng HW, Lin BW, Liang YH, Su YL, Hsu HC, Kuan FC, Chou YH, Lin J, Lin BR, Chang YY, Wang JY. Chen HH, et al. Among authors: chen cc. Front Oncol. 2021 Nov 15;11:764912. doi: 10.3389/fonc.2021.764912. eCollection 2021. Front Oncol. 2021. PMID: 34868987 Free PMC article. Review.
Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
Chen HH, Lin JK, Chen JB, Chuang CH, Liu MC, Wang JY, Changchien CR. Chen HH, et al. Among authors: chen jb. Asia Pac J Clin Oncol. 2018 Feb;14(1):61-68. doi: 10.1111/ajco.12692. Epub 2017 Sep 14. Asia Pac J Clin Oncol. 2018. PMID: 28906589 Clinical Trial.
2,910 results